$ALKS
Alkermes plc.

2019 Q1 Form 10-Q Financial Statement

#000156459019012913 Filed on April 25, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q1
Revenue $223.1M $225.2M
YoY Change -0.91% 17.39%
Cost Of Revenue $45.36M $44.48M
YoY Change 1.99% 10.09%
Gross Profit $177.7M $180.7M
YoY Change -1.62% 19.34%
Gross Profit Margin 79.67% 80.25%
Selling, General & Admin $141.2M $118.1M
YoY Change 19.53% 15.72%
% of Gross Profit 79.45% 65.39%
Research & Development $102.6M $108.3M
YoY Change -5.33% 3.38%
% of Gross Profit 57.71% 59.97%
Depreciation & Amortization $19.64M $25.72M
YoY Change -23.64% 8.08%
% of Gross Profit 11.05% 14.24%
Operating Expenses $243.8M $226.5M
YoY Change 7.64% 1.93%
Operating Profit -$76.00M -$61.89M
YoY Change 22.8% -12.59%
Interest Expense $3.500M $5.487M
YoY Change -36.21% -404.83%
% of Operating Profit
Other Income/Expense, Net -$24.25M -$5.110M
YoY Change 374.58% -5210.0%
Pretax Income -$100.3M -$67.00M
YoY Change 49.63% -7.72%
Income Tax -$3.854M -$4.493M
% Of Pretax Income
Net Earnings -$96.40M -$62.51M
YoY Change 54.22% -9.28%
Net Earnings / Revenue -43.21% -27.76%
Basic Earnings Per Share
Diluted Earnings Per Share -$616.8K -$404.8K
COMMON SHARES
Basic Shares Outstanding 156.0M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $582.1M $404.6M
YoY Change 43.87% -15.07%
Cash & Equivalents $225.2M $186.5M
Short-Term Investments $356.9M $218.1M
Other Short-Term Assets $56.50M $46.50M
YoY Change 21.51% 9.93%
Inventory $92.90M $84.90M
Prepaid Expenses
Receivables $231.3M $240.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $962.7M $776.1M
YoY Change 24.04% 2.27%
LONG-TERM ASSETS
Property, Plant & Equipment $320.0M $289.6M
YoY Change 10.5% 9.32%
Goodwill $92.87M
YoY Change
Intangibles
YoY Change
Long-Term Investments $48.60M $141.5M
YoY Change -65.65% 21.88%
Other Assets $133.3M $196.4M
YoY Change -32.13% 1.13%
Total Long-Term Assets $793.8M $960.5M
YoY Change -17.36% -1.07%
TOTAL ASSETS
Total Short-Term Assets $962.7M $776.1M
Total Long-Term Assets $793.8M $960.5M
Total Assets $1.757B $1.737B
YoY Change 1.15% 0.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.96M $65.40M
YoY Change -25.14% 15.34%
Accrued Expenses $273.8M $202.7M
YoY Change 35.08% 36.41%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.843M $2.800M
YoY Change 1.54% -6.67%
Total Short-Term Liabilities $327.7M $274.5M
YoY Change 19.38% 30.28%
LONG-TERM LIABILITIES
Long-Term Debt $275.9M $278.1M
YoY Change -0.78% -0.71%
Other Long-Term Liabilities $28.43M $28.00M
YoY Change 1.52% 25.56%
Total Long-Term Liabilities $304.3M $306.1M
YoY Change -0.57% 1.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $327.7M $274.5M
Total Long-Term Liabilities $304.3M $306.1M
Total Liabilities $654.4M $580.7M
YoY Change 12.69% 13.17%
SHAREHOLDERS EQUITY
Retained Earnings -$1.282B $900.0K
YoY Change -142518.44%
Common Stock $2.504B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.102B $1.156B
YoY Change
Total Liabilities & Shareholders Equity $1.757B $1.737B
YoY Change 1.15% 0.39%

Cashflow Statement

Concept 2019 Q1 2018 Q1
OPERATING ACTIVITIES
Net Income -$96.40M -$62.51M
YoY Change 54.22% -9.28%
Depreciation, Depletion And Amortization $19.64M $25.72M
YoY Change -23.64% 8.08%
Cash From Operating Activities $22.21M -$26.84M
YoY Change -182.76% 95.9%
INVESTING ACTIVITIES
Capital Expenditures $23.64M $18.49M
YoY Change 27.88% -296.65%
Acquisitions
YoY Change
Other Investing Activities -$41.10M $43.80M
YoY Change -193.84% 76.61%
Cash From Investing Activities -$64.70M $25.34M
YoY Change -355.3% 63.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $711.0K
YoY Change
Cash From Financing Activities 963.0K -3.297M
YoY Change -129.21% -51.51%
NET CHANGE
Cash From Operating Activities 22.21M -26.84M
Cash From Investing Activities -64.70M 25.34M
Cash From Financing Activities 963.0K -3.297M
Net Change In Cash -41.53M -4.791M
YoY Change 766.79% -4.18%
FREE CASH FLOW
Cash From Operating Activities $22.21M -$26.84M
Capital Expenditures $23.64M $18.49M
Free Cash Flow -$1.427M -$45.32M
YoY Change -96.85% 954.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2018Q1 alks Operating Lease Provision For Extension Of Term
OperatingLeaseProvisionForExtensionOfTerm
P10Y
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
1102141000
CY2019Q1 alks Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
1516000
CY2019Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-790000
CY2019Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13420000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18010000
CY2018Q4 us-gaap Deferred Tax Assets Gross Noncurrent
DeferredTaxAssetsGrossNoncurrent
85807000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
16143000
CY2018Q4 us-gaap Assets
Assets
1825007000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
333762000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3169000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8795000
CY2019Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2843000
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2843000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
327685000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
339774000
CY2019Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
275923000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
276465000
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
28425000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
27958000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11020000
CY2019Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
11342000
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
9525000
CY2019Q1 us-gaap Liabilities
Liabilities
654395000
CY2018Q4 us-gaap Liabilities
Liabilities
653722000
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
159577874
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
158180833
CY2019Q1 us-gaap Interest Expense
InterestExpense
3500000
CY2018Q1 us-gaap Interest Expense
InterestExpense
5487000
CY2019Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-22600000
CY2018Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-1900000
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
156885028
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
155757344
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
1593000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
1579000
CY2019Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2692846
CY2018Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2423489
CY2019Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
117949000
CY2018Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
108969000
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2502773000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2467323000
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2510000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3280000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1281766000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1185368000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
1102141000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1171285000
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1756536000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1825007000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
223102000
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
225150000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
45361000
CY2018Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
44476000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
102570000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
108346000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
141220000
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
118147000
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9952000
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16069000
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
299103000
CY2018Q1 us-gaap Costs And Expenses
CostsAndExpenses
287038000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-76001000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-61888000
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3570000
CY2018Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1485000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1721000
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
792000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-24251000
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5110000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-100252000
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-66998000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3854000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4493000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-96398000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-62505000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.62
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.40
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
156336000
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
154424000
CY2019Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
69000
CY2018Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-890000
CY2019Q1 alks Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
-2131000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-15888000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-14123000
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
725000
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8880000
CY2018Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
245000
CY2019Q1 alks Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2297000
CY2019Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1765000
CY2018Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2669000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22212000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26838000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-96398000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-62505000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
229000
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-100000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
770000
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-336000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-95628000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-62841000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-96398000
CY2018Q1 us-gaap Profit Loss
ProfitLoss
-62505000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19642000
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25722000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
24616000
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
20042000
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3225000
CY2018Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4101000
CY2019Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-22600000
CY2018Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-1900000
CY2018Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2298000
CY2018Q1 us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
1840000
CY2019Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
1116000
CY2018Q1 us-gaap Other Noncash Income
OtherNoncashIncome
75000
CY2019Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-69411000
CY2018Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-19430000
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
217000
CY2018Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
16959000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1700000
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
431000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23639000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18485000
CY2019Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
85000
CY2018Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
324000
CY2019Q1 alks Proceeds From Contingent Consideration
ProceedsFromContingentConsideration
5000000
CY2019Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
102127000
CY2018Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
35995000
CY2019Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
55978000
CY2018Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
79500000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-64703000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
25344000
CY2019Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
10554000
CY2018Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
13164000
CY2018Q1 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
-1692000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-62505000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
1155891000
CY2018Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15724000
CY2019Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
711000
CY2018Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
737000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
963000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3297000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-41528000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4791000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
266762000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
191296000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
225234000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
186505000
CY2019Q1 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
7850000
CY2018Q1 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
7516000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1171285000
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10554000
CY2019Q1 alks Receipt Of Company Stock For Exercise Of Stock Options Or To Satisfy Minimum Tax Withholding Obligations Related To Stock Based Awards Value
ReceiptOfCompanyStockForExerciseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue
-8880000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24810000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
229000
CY2019Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
770000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-96398000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
1202808000
CY2018Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13165000
CY2018Q1 alks Receipt Of Company Stock For Exercise Of Stock Options Or To Satisfy Minimum Tax Withholding Obligations Related To Stock Based Awards Value
ReceiptOfCompanyStockForExerciseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue
-15724000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20176000
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-100000
CY2018Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-337000
CY2019Q1 us-gaap Nature Of Operations
NatureOfOperations
<p id="N1_COMPANY" style="margin-top:10pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1. THE COMPANY</p> <p style="margin-top:10pt;margin-bottom:0pt;text-indent:3.7%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Alkermes plc (the “Company”) is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to research, develop and commercialize, both with partners and on its own, pharmaceutical products that are designed to address unmet medical needs of patients in major therapeutic areas. The Company has a diversified portfolio of commercial drug products and a clinical pipeline of product candidates focused on central nervous system (“CNS”) disorders such as schizophrenia, depression, addiction and multiple sclerosis (“MS”), and oncology. Headquartered in Dublin, Ireland, the Company has a research and development (“R&amp;D”) center in Waltham, Massachusetts; R&amp;D and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. </p>
CY2019Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
8447000
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
12694000
CY2019Q1 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1769000
CY2019Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
3487000
CY2019Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3589000
CY2019Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:10pt;margin-bottom:0pt;text-indent:3.7%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the Company’s condensed consolidated financial statements in accordance with GAAP requires management to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, judgments and methodologies, including those related to revenue recognition and related allowances, its collaborative relationships, clinical trial expenses, the valuation of inventory, impairment and amortization of intangibles and long-lived assets, share-based compensation, income taxes including the valuation allowance for deferred tax assets, valuation of investments, contingent consideration and litigation. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions.</p>
CY2019Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20100000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
22100000
CY2018Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
8230000
CY2019Q1 alks Contract With Customer Asset Additions
ContractWithCustomerAssetAdditions
7346000
CY2019Q1 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
7129000
CY2019Q1 alks Long Term Investment Securities Unrealized Gain Loss
LongTermInvestmentSecuritiesUnrealizedGainLoss
102000
CY2019Q1 alks Long Term Investment Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
LongTermInvestmentSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
88000
CY2019Q1 alks Long Term Investment Securities Continuous Unrealized Loss Position More Than12 Months Aggregate Losses
LongTermInvestmentSecuritiesContinuousUnrealizedLossPositionMoreThan12MonthsAggregateLosses
50000
CY2019Q1 us-gaap Long Term Investments
LongTermInvestments
43005000
CY2019Q1 alks Marketable Securities At Amortized Cost
MarketableSecuritiesAtAmortizedCost
399415000
CY2019Q1 alks Marketable Investments Securities Unrealized Gain Loss
MarketableInvestmentsSecuritiesUnrealizedGainLoss
901000
CY2019Q1 alks Marketable Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
MarketableSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
103000
CY2019Q1 alks Marketable Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses
MarketableSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses
314000
CY2019Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
399899000
CY2018Q4 alks Long Term Investment Securities Unrealized Gain Loss
LongTermInvestmentSecuritiesUnrealizedGainLoss
136000
CY2018Q4 alks Long Term Investment Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
LongTermInvestmentSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
210000
CY2018Q4 alks Long Term Investment Securities Continuous Unrealized Loss Position More Than12 Months Aggregate Losses
LongTermInvestmentSecuritiesContinuousUnrealizedLossPositionMoreThan12MonthsAggregateLosses
105000
CY2018Q4 us-gaap Long Term Investments
LongTermInvestments
80744000
CY2018Q4 alks Marketable Securities At Amortized Cost
MarketableSecuritiesAtAmortizedCost
353758000
CY2018Q4 alks Marketable Investments Securities Unrealized Gain Loss
MarketableInvestmentsSecuritiesUnrealizedGainLoss
393000
CY2018Q4 alks Marketable Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
MarketableSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
291000
CY2018Q4 alks Marketable Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses
MarketableSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses
583000
CY2018Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
353277000
CY2019Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
55978000
CY2018Q1 alks Marketable Securities Realized Gain
MarketableSecuritiesRealizedGain
1000
CY2019Q1 alks Marketable Securities Realized Loss
MarketableSecuritiesRealizedLoss
492000
CY2019Q1 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
1820000
CY2019Q1 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
1667000
CY2019Q1 alks Fair Value Recurring Basis Assets Or Liabilities Transfers Between Levels
FairValueRecurringBasisAssetsOrLiabilitiesTransfersBetweenLevels
0
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
66897000
CY2019Q1 alks Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Payment Received For Contingent Consideration
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPaymentReceivedForContingentConsideration
5000000
CY2019Q1 alks Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Impairment Of Corporate Debt Security
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairmentOfCorporateDebtSecurity
492000
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
38372000
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
31824000
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
38019000
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
20353000
CY2018Q4 us-gaap Inventory Net
InventoryNet
90196000
CY2018Q4 alks Inventory Finished Goods Net Of Reserves Located At Third Party Warehouse And Shipping Service Provider
InventoryFinishedGoodsNetOfReservesLocatedAtThirdPartyWarehouseAndShippingServiceProvider
11000000.0
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
39767000
CY2019Q1 us-gaap Due To Employees Current
DueToEmployeesCurrent
48653000
CY2018Q4 us-gaap Due To Employees Current
DueToEmployeesCurrent
67613000
CY2019Q1 alks Accrued Sales Discounts Allowances And Reserves
AccruedSalesDiscountsAllowancesAndReserves
140736000
CY2018Q4 alks Accrued Sales Discounts Allowances And Reserves
AccruedSalesDiscountsAllowancesAndReserves
152911000
CY2019Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
75624000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
73471000
CY2019Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
313969000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
333762000
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
607081000
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
287077000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
320004000
CY2019Q1 us-gaap Goodwill Gross
GoodwillGross
92873000
CY2019Q1 us-gaap Goodwill
Goodwill
92873000
CY2019Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
582750000
CY2019Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
401701000
CY2019Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
181049000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
40000000.0
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
40000000.0
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
40000000.0
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
35000000.0
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
35000000.0
CY2019Q1 alks Number Of Additional Operating Leases
NumberOfAdditionalOperatingLeases
2
CY2019Q1 alks Weighted Average Incremental Borrowing Rate
WeightedAverageIncrementalBorrowingRate
0.0446
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18000000.0
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
19800000
CY2019Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
2100000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
6806000
CY2018Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
9394000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
8652000
CY2018Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
10717000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2520000
CY2018Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4706000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
500000
CY2018Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2455000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
509000
CY2018Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2389000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3100000
CY2018Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
23940000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
22087000
CY2018Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
53601000
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2272000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
19815000
CY2018Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
53601000
CY2018Q1 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
220000
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
48956000
CY2019Q1 alks Number Of Lender Holding Percentage Of Outstanding Amount
NumberOfLenderHoldingPercentageOfOutstandingAmount
1
CY2019Q1 alks Percentage Of Outstanding Principal Amount Held By Lender
PercentageOfOutstandingPrincipalAmountHeldByLender
0.01
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24616000
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20042000
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14754000
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13025000
CY2019Q1 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
0
CY2019Q1 alks Number Of Separate Paragraph Four Notices
NumberOfSeparateParagraphFourNotices
11
CY2019Q1 alks Maximum Period For Lawsuit Related To Paragraph Four Certification Notice
MaximumPeriodForLawsuitRelatedToParagraphFourCertificationNotice
P45D
CY2019Q1 alks Minimum Period Before Fda Can Approve Patent Request
MinimumPeriodBeforeFdaCanApprovePatentRequest
P30M
CY2019Q1 alks Number Of Abbreviated New Drug Application Filers Consolidated To Single Case
NumberOfAbbreviatedNewDrugApplicationFilersConsolidatedToSingleCase
8
CY2019Q1 us-gaap Loss Contingency Lawsuit Filing Date
LossContingencyLawsuitFilingDate
April 11, 2019
CY2019Q1 us-gaap Loss Contingency Date Of Dismissal
LossContingencyDateOfDismissal
2019-05-02

Files In Submission

Name View Source Status
0001564590-19-012913-index-headers.html Edgar Link pending
0001564590-19-012913-index.html Edgar Link pending
0001564590-19-012913.txt Edgar Link pending
0001564590-19-012913-xbrl.zip Edgar Link pending
alks-10q_20190331.htm Edgar Link pending
alks-10q_20190331_htm.xml Edgar Link completed
alks-20190331.xsd Edgar Link pending
alks-20190331_cal.xml Edgar Link unprocessable
alks-20190331_def.xml Edgar Link unprocessable
alks-20190331_lab.xml Edgar Link unprocessable
alks-20190331_pre.xml Edgar Link unprocessable
alks-ex101_85.htm Edgar Link pending
alks-ex311_20.htm Edgar Link pending
alks-ex312_9.htm Edgar Link pending
alks-ex321_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gddbpcxtuukn000001.jpg Edgar Link pending
gddbpcxtuukn000002.jpg Edgar Link pending
gddbpcxtuukn000003.jpg Edgar Link pending
gpdpgpteb4xb000001.jpg Edgar Link pending
gpdpgpteb4xb000002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending